|Articles|October 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-10-01-2001
  • Volume 0
  • Issue 0

Illegal Sales in India

Author(s)Kevin Gopal

Mumbai, India—The controversy over pharma companies’ incentives to pharmacists in India highlights just how competitive the Indian pharma industry has become.

Articles in this issue

about 25 years ago

PBMs: Merck-Medco in the Hot Seat

about 25 years ago

Weak Bones, Strong Market

about 25 years ago

Approvals: Novartis’ Silver Lining

about 25 years ago

Pfizer and others Pitch In

about 25 years ago

Oncology: EMEA Approval Lags

about 25 years ago

Little Elan Becomes a Big Deal

Related to this article